In this study, we demonstrated that the VRCZ metabolites are phototoxic agents serving as an initiator of tumorigenesis, and VRCZ per se is an AhR-COX-2 activator functioning as a promoter of tumor development (Fig. 6). This evidence concerns the gene AHR and neoplasm.